<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02006134</url>
  </required_header>
  <id_info>
    <org_study_id>H12-00894</org_study_id>
    <secondary_id>TR2-119188</secondary_id>
    <nct_id>NCT02006134</nct_id>
  </id_info>
  <brief_title>Pediatric Vasculitis Initiative</brief_title>
  <acronym>PedVas</acronym>
  <official_title>Chronic Childhood Vasculitis: Characterizing the Individual Rare Diseases to Improve Patient Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Simon Fraser University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Child and Family Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alberta Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Childhood chronic vasculitis describes a group of rare life-threatening diseases that have in
      common inflammation of blood vessels in vital organs such as kidneys, lungs and brain. Most
      knowledge about them comes from adult patients. Severe disease requires aggressive
      life-saving treatments with steroids and some cancer drugs which can themselves cause damage,
      and increase risks of cancer and severe infections. Conversely, milder disease can be treated
      with less toxic drugs. Different classification and &quot;scoring tools&quot; are used to define the
      types and severity of vasculitis and to measure damage caused by disease or drugs. These in
      turn help direct how aggressively to treat a patient and to measure outcome. None of these
      tools however have been assessed in children and the best balance of disease and treatment
      risks against outcome for children is not known. Although causes of these diseases in
      children and adults are probably the same, the effects of the disease and the response (good
      and bad) to drugs will differ in growing children. Because specialists may see only one new
      child with vasculitis each year, obtaining enough information to learn about childhood
      vasculitis requires cooperation. We will use an international web-based registry to which
      doctors from 50 or more centers can contribute patient data. We will determine the features
      which help better classify and diagnose children compared to adults. Through the web we will
      collect and analyze information on patients similarly classified and &quot;scored&quot; so that most
      successful treatments can be identified. Children with vasculitis are less likely to have
      diseases associated with aging, alcohol and smoking etc., and therefore may be a better group
      in whom to study the underlying biology of vasculitis. We will use this opportunity and
      collect spit, blood and tissue from registry patients for laboratory study with an aim to
      find biomarkers to better classify, define and direct optimal treatment and outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over a 3-year period, we anticipate enrollment and collection of clinical data from as many
      as 600 children with various forms of childhood vasculitis, with approximately one third
      (200) of those children also contributing biological samples for study.

      For children with vasculitis who are enrolled in the study, clinical information will be
      obtained from the medical chart from the time of diagnosis, post-induction (3-6 months post
      diagnosis) visit, 12-month clinic visit, and their most recent clinic visit or last clinic
      visit before discharge to adult care (ie. final outcome visit). Information that will be
      collected includes laboratory test results, biopsy and imaging results, disease activity,
      clinical history, and medications. Blood, urine, and saliva samples will also be collected at
      each clinic visit. If the subject experiences a disease flare, clinical data and biological
      samples will be collected at the time of the flare and at a later date when the disease
      remits.

      The PedVas study is linked to an adult vasculitis initiative called DCVAS: Diagnosis and
      Classification Criteria in Vasculitis. Our DCVAS co-investigators and collaborators will
      recruit up to 250 adults at or near the time of diagnosis of the following forms of
      vasculitis: GPA, MPA, EGPA, TA, and UCV. Clinical data will be collected as part of the DCVAS
      study; this includes information such as laboratory test results, disease activity, and
      clinical history. Blood will also be collected and analyzed in parallel with samples
      collected from children with vasculitis. Finally, a DNA-biobank will be created and will
      house samples from approximately 700 adults and representing all forms of vasculitis.
      Recruitment will proceed according to DCVAS approved protocols and it will be conducted at
      participating DCVAS centres after the patient has formally consented to participation in the
      DCVAS study.

      Healthy volunteers from the community will be recruited to participate in this study by word
      of mouth and recruitment posters. Participation for children involves a one-time donation of
      blood and a urine sample, while adults may donate blood and urine up to 4 times over the
      course of 18 months.

      All biological samples will be processed and analyzed in Vancouver at the Child and Family
      Research Institute and at the University of British Columbia. Detailed data will be collected
      in electronic format and include demographic variables, socioeconomic status, detailed
      clinical history &amp; physical findings, anthropometric measures, and measures of disease
      activity. All data for systemic vasculitis patients will be directly entered at each site
      into a secure, online, web-based data entry system called REDCap which is managed through the
      data management centre at the University of British Columbia in Vancouver. All CNS vasculitis
      data will be entered into the Brainworks database which is managed by the data management
      team at the Hospital for Sick Kids in Toronto.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Develop new benchmarks for outcome in pediatric patients with systemic or CNS vasculitis</measure>
    <time_frame>within 3 yrs</time_frame>
    <description>Specific and generic disease assessment tools will be used to analyze our registry cohorts to enable the first-ever benchmarks of outcome in children with GPA or PACNS who have had a minimum of 12 months follow up.</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Wegeners Granulomatosis (Granulomatosis With Polyangiitis)</condition>
  <condition>Microscopic Polyangiitis</condition>
  <condition>Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis)</condition>
  <condition>Polyarteritis Nodosa</condition>
  <condition>Takayasu Arteritis</condition>
  <condition>Primary CNS Vasculitis</condition>
  <condition>Unclassified Vasculitis</condition>
  <arm_group>
    <arm_group_label>PEDIATRIC VASCULITIS/PROSPECTIVE</arm_group_label>
    <description>Pediatric patients in this cohort are those diagnosed with vasculitis within 12 months from study entry. Clinical data, blood (RNA, plasma, serum), urine, and saliva (DNA) will be collected at 3 to 5 timepoints: time-of-diagnosis, post-induction, 12-month post diagnosis, disease flare, and remission/post-flare.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEDIATRIC VASCULITIS/RETROSPECTIVE</arm_group_label>
    <description>Patients in this cohort are those diagnosed with vasculitis more than 12 months from study entry and/or were previously enrolled in the ARChiVe or Brainworks registries. Clinical outcome data will be collected retrospectively. Blood (RNA &amp; serum), urine, and saliva (DNA) will be collected at 2 timepoints: disease flare, and remission/post-flare.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADULT VASCULITIS/ COHORT 1</arm_group_label>
    <description>Adult patients in this cohort are those at or near the time of diagnosis of GPA, MPA, EGPA or unclassified vasculitis that are participants in DCVAS. Clinical data and blood (RNA, DNA) will be collected at the time-of-diagnosis only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADULT VASCULITIS / COHORT 2</arm_group_label>
    <description>Adult patients in this cohort are those individuals that are participants in DCVAS and have any form of vasculitis. Clinical data and blood (DNA) collected at the time-of-diagnosis will be used for study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HEALTHY CHILDREN / PEDIATRIC CONTROL</arm_group_label>
    <description>Participants in this cohort are otherwise healthy children with no history of inflammatory disease. Children will provide a one time donation of blood (RNA, serum) and urine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HEALTHY ADULTS / ADULT CONTROL</arm_group_label>
    <description>Participants in this cohort are otherwise healthy adults with no history of inflammatory disease. Adults will provide a one time donation urine and will provide blood (RNA, serum) as many as 4 times.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, biopsy tissue, urine, DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children or adolescents diagnosed with vasculitis at any of the participating PedVas study
        centres
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for vasculitis subjects:

          -  Diagnosed with ANCA-associated vasculitis (AAV: such as Granulomatosis with
             Polyangiitis (GPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA) and
             Microscopic Polyangiitis (MPA)), Primary Angiitis of the Central Nervous System
             (PACNS), Unclassified vasculitis, Takayasu's Arteritis (TA) or Polyarteritis Nodosa
             (PAN) before age 18

        Inclusion criteria for healthy controls:

          -  Healthy adult or child

        Exclusion Criteria for vasculitis subjects:

          -  Diagnosed with other vasculitis subtypes not listed above

          -  More than 20 years of age

        Exclusion criteria for healthy controls:

          -  Donated greater than 20 ml of blood in the previous three weeks

          -  Has an immune disorder or blood borne infectious diseases (such as HIV or Hepatitis)

          -  Has vasculitis, multiple sclerosis, diabetes, an autoimmune disease, a thyroid
             condition, or other chronic conditions involving the heart, lungs, gut or kidney

          -  Has a previous history of anaemia or abnormal blood clotting

          -  Has a current or previous drug abuse problem
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Cabral, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia; BC Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susanne Benseler, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alberta Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raashid Luqmani, DM FRCP(E)</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dirk Foell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Muenster</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Hancock, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Colin Ross, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jinko Graham, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Simon Fraser University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angelyne Sarmiento</last_name>
    <email>pedvas@cw.bc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Erica Lawson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Melissa Elder, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Georgia</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rita Jerath, MB ChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comer Children's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Linda Wagner-Weiner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kathleen O'Neil</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kenneth Schikler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Joseph M. Sanzari Children's Hospital</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Suzanne Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital at Montefiore</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dawn Wahezi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akron Children's Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mary Toth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Eyal Muscal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah / Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Aimee Hersh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Susan Shenoi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Pediatría Garrahan</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ricardo Russo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary / Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Susanne Benseler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Cabral, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Janeway Childrens Health and Rehabilitation Centre</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paul Dancey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IIWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Adam Huber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberta Berard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ciaran Duffy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Susanne Benseler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rae Yeung, MD, PhD, FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alan Rosenberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Susan Nielsen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Munster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dirk Foell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanjay Gandhi Post Graduate Institute</name>
      <address>
        <city>Lucknow</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Amita Aggarwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meyer Children's Hospital of Florence</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rolando Cimaz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Pediatria</name>
      <address>
        <city>Coyoacán</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ana Luisa Rodriguez Lozano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg State Pediatric Medical University</name>
      <address>
        <city>Saint Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mikhail Kostik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mother and Child Health Care Institute of Serbia</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Goran Ristic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan de Deu</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jordi Anton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sirirat Charuvanij, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Birmingham Children's Hospital NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Taunton Southwood</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Hospital for Children</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Neil Martin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leeds Children's Hospital</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Mark Wood</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alder Hey Children's Hospital</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Eileen Baildam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Manchester Children's Hospital</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Janet McDonagh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Great North Children's Hospital</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Mark Friswell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham Children's Hospital</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lampros Fotis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nuffield Orthopaedic Centre</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Raashid Luqmani, DM FRCP, FRCP(E)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheffield Children's Foundation Trust</name>
      <address>
        <city>Sheffield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Anne-Marie McMahon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ukpedvas@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Alice Leahy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>India</country>
    <country>Italy</country>
    <country>Mexico</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Thailand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.sickkids.ca/Research/Brainworks/the-brainworks-study/index.html</url>
    <description>BrainWorks: The International Childhood CNS Vasculitis Outcome Study</description>
  </link>
  <link>
    <url>https://research.ndorms.ox.ac.uk/public/dcvas/</url>
    <description>DCVAS: Diagnostic and Classification Criteria in Vasculitis Study</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2013</study_first_submitted>
  <study_first_submitted_qc>December 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2013</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>David Cabral</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Vasculitis</keyword>
  <keyword>Primary CNS Vasculitis</keyword>
  <keyword>Systemic vasculitis</keyword>
  <keyword>Churg-Strauss Syndrome</keyword>
  <keyword>Polyarteritis Nodosa</keyword>
  <keyword>Wegener Granulomatosis</keyword>
  <keyword>Pediatric vasculitis</keyword>
  <keyword>Childhood vasculitis</keyword>
  <keyword>Granulomatosis with polyangiitis</keyword>
  <keyword>Microscopic Polyangiitis</keyword>
  <keyword>Takayasu Arteritis</keyword>
  <keyword>Autoimmune</keyword>
  <keyword>ANCA-associated vasculitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Systemic Vasculitis</mesh_term>
    <mesh_term>Granulomatosis with Polyangiitis</mesh_term>
    <mesh_term>Microscopic Polyangiitis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
    <mesh_term>Churg-Strauss Syndrome</mesh_term>
    <mesh_term>Polyarteritis Nodosa</mesh_term>
    <mesh_term>Vasculitis, Central Nervous System</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

